Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.76438 | 32 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.72308 | 32 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.741 | 33 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.6354 | 30 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.64489 | 30 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.8083 | 32 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.75807 | 31 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.69659 | 31 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.6747 | 31 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.17375 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.70902 | 32 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.6643 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.71407 | 31 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.71384 | 32 |